Revolution Medicines Inc share price logo

Revolution Medicines Inc Share Price

NASDAQ: RVMD

Mid Cap

$77.79

+0.21

(+0.27%)

as on

Revolution Medicines Inc Stock Performance

as on November 28, 2025 at 11:29 pm IST

  • Day's Low

    Day's High

    $76.6
    $77.98
    downward going graph

    1.53%

    Downside

    0.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.17
    $78.17
    downward going graph

    62.50%

    Downside

    0.48%

    Upside

    downward going graph

Revolution Medicines Inc share price movements today

Previous Close
$77.58
Open
$77.58
Volume
564.0K
Day's Low - High
$76.6 - $77.98
52 Week Low - High
$29.17 - $78.17

Revolution Medicines Inc Historical Returns

1 Month Return
+ 34.02 %
3 Month Return
+ 104.79 %
1 Year Return
+ 34.42 %
3 Year Return
+ 243.46 %
5 Year Return
+ 76.85 %

Revolution Medicines Inc Stock Fundamentals & Key Indicators

Check Revolution Medicines Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.0B

EPS (TTM)

-5.5362

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.45

Industry PE ratio

8.214070796460177

PEG Ratio

0

EBITDA

-1.0B

Revenue (TTM)

742.0K

Profit Margin

0.00%

Return On Equity TTM

-60.76%

Revolution Medicines Inc Stock Valuation

Track how Revolution Medicines Inc P/E has moved over time to understand its valuation trends.

Revolution Medicines Inc in the last 5 years

  • Overview

  • Trends

Lowest (-23.23x)

March 31, 2021

Today (-13.45x)

November 29, 2025

Industry (8.21x)

November 29, 2025

Highest (-6.37x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -13.45x

Revolution Medicines Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Revolution Medicines Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$15.0B76.85%-13.450.00%
BUY$44.3B422.04%-16.34-264.83%
BUY$58.8B247.47%1435.871.36%
BUY$110.8B91.26%30.3931.35%
BUY$83.2B51.77%18.832.13%

Stock Returns calculator for Revolution Medicines Inc Stock including INR - Dollar returns

The Revolution Medicines Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Revolution Medicines Inc investment value today

Current value as on today

₹1,40,107

Returns

₹40,107

(+40.11%)

Returns from Revolution Medicines Inc Stock

₹34,468 (+34.47%)

Dollar Returns*

₹5,638 (+5.64%)

Analyst Recommendation on Revolution Medicines Inc Stock

Based on 19 analysts

BUY

94.74%

Buy

5.26%

Hold

0.00%

Sell

Based on 19 analysts, 94.74% of analysts recommend a 'BUY' rating for Revolution Medicines Inc. Average target price of $81.15

Revolution Medicines Inc Share Price Target

Get share price movements and forecasts by analysts on Revolution Medicines Inc.

What analysts predicted

4.14%UPSIDE

Target Price

$81.15

Current Price

$77.79

Analyzed by

19 Analysts

Target

$81.15

Revolution Medicines Inc target price $81.15, a slight upside of 4.14% compared to current price of $77.79. According to 19 analysts rating.

Revolution Medicines Inc Stock’s Investor Sentiment and Interest

Search interest for Revolution Medicines Inc Stock has increased by 207% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:207% versus previous 30 day period

Revolution Medicines Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
3
-
0
-
-
-
261
-
-
-
Gross Profit
-3
-107
-135
-118
-12
-151
-188
-205
-3
-
Operating Income
-108
-123
-179
-140
-156
-175
-216
-240
-264
-315
EBITDA
-107
-121
-129
-138
-153
-172
-212
-237
-260
-302
Interest Expense
-
-
9
-
-
-
-
-
0
11
Depreciation
1
2
2
2
2
2
3
3
3
4
Income Before Tax
-98
-112
-161
-116
-133
-156
-195
-213
-247
-305
Income Tax Expense
-1
-3
0
-2
-
-156
0
-
-
-
Net Income
-98
-108
-161
-116
-133
-156
-194
-213
-247
-305
Net Profit Margin
-2570.55%
0.00%
-21770.49%
0.00%
0.00%
0.00%
-74.38%
0.00%
0.00%
0.00%

Revolution Medicines Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
20
50
42
29
35
11
-
Gross Profit
-26
-30
-41
-89
-157
-217
-399
-592
Operating Income
-31
-40
-54
-110
-188
-258
-487
-689
EBITDA
-29
-39
-48
-101
-179
-248
-456
-589
Interest Expense
0
0
0
0
0
9
0
-
Depreciation
1
1
3
6
7
9
9
11
Income Before Tax
-31
-41
-52
-108
-187
-249
-439
-600
Income Tax Expense
0
-1
-4
0
-7
0
-3
0
Net Income
-31
-41
-47
-108
-187
-248
-436
-600
Net Profit Margin
0.00%
-207.24%
-95.25%
-251.63%
-636.58%
-702.95%
-3768.28%
0.00%

Revolution Medicines Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-108
-161
-116
-133
-156
-194
-213
-247
-305
Operating Cash Flow
-100
-120
-160
-128
-130
-138
-194
-221
-207
Investing Cash Flow
77
-380
-247
107
-21
-392
-15
34
24
Financing Cash Flow
1
839
0
7
77
873
0
256
-1
Change in Cash
-21
337
-407
-12
-74
341
-209
69
-184

Revolution Medicines Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-41
-47
-108
-187
-248
-436
-600
Operating Cash Flow
1
-49
-100
-147
-224
-350
-557
Investing Cash Flow
-1
-101
-234
-142
-24
-342
-554
Financing Cash Flow
60
98
422
294
301
1,229
959
Change in Cash
60
-52
88
4
52
534
-153

Global Institutional Holdings in Revolution Medicines Inc

Funds
Holdings
Vanguard Group Inc
8.43%
Farallon Capital Management, L.L.C.
7.66%
HHG PLC
5.67%
Wellington Management Company LLP
5.49%
Baker Bros Advisors LP
5.01%

Revolution Medicines Inc News & Key Events

  • img

    Today's Timeline - 27 October

    Mon, 05:48 PM

    -

    Revolution Medicines receives FDA Orphan Drug Designation for daraxonrasib, targeting pancreatic cancer treatment.

Insights on Revolution Medicines Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 742.0K → 261.59M (in $), with an average increase of 99.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, RVMD stock has moved up by 32.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 1023.7% return, outperforming this stock by 794.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 142.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 7 quarters, -116.00M → -305.20M (in $), with an average decrease of 17.6% per quarter

About Revolution Medicines Inc

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
OrganisationRevolution Medicines Inc
Headquarters700 Saginaw Drive, Redwood City, CA, United States, 94063
IndustryHealth Technology
CEODr. Mark A. Goldsmith M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Revolution Medicines Inc

Name

Title

Ms. Xiaolin Wang

Executive Vice President of Development

Mr. Walter Reiher Ph.D.

Chief Information Officer

Ms. Jan Smith Ph.D.

Chief Scientific Officer

Mr. Jack Anders

Chief Financial Officer

Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.

President of Research & Development

Dr. Martin D. Burke M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Dr. Michael A. Fischbach Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

Dr. Kevan M. Shokat Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

Dr. Mark A. Goldsmith M.D., Ph.D.

CEO, President & Chairman

Ms. Margaret A. Horn J.D.

Chief Operating Officer

FAQs

What is Revolution Medicines Inc share price today?

Revolution Medicines Inc share price today is $77.79 as on at the close of the market. Revolution Medicines Inc share today touched a day high of $77.98 and a low of $76.6.

What is the 52 week high and 52 week low for Revolution Medicines Inc share?

Revolution Medicines Inc share touched a 52 week high of $78.17 on and a 52 week low of $29.17 on . Revolution Medicines Inc stock price today i.e. is closed at $77.79,which is 0.48% down from its 52 week high and 166.68% up from its 52 week low.

What is Revolution Medicines Inc's market capitalisation today?

Revolution Medicines Inc market capitalisation is $0.01T as on .

How to invest in Revolution Medicines Inc Stock (RVMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Revolution Medicines Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revolution Medicines Inc Shares that will get you 0.0193 shares as per Revolution Medicines Inc share price of $77.79 per share as on November 28, 2025 at 11:29 pm IST.

What is the minimum amount required to buy Revolution Medicines Inc Stock (RVMD) from India?

Indian investors can start investing in Revolution Medicines Inc (RVMD) shares with as little as ₹89.332 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.32 in Revolution Medicines Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Revolution Medicines Inc share’s latest price of $77.79 as on November 28, 2025 at 11:29 pm IST, you will get 0.1286 shares of Revolution Medicines Inc. Learn more about fractional shares .

What are the returns that Revolution Medicines Inc has given to Indian investors in the last 5 years?

Revolution Medicines Inc stock has given 76.85% share price returns and 20.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?